[en] IGF-II is a polypeptide growth factor with growth and differentiation promoting activities, involved in human development. We have reported previously IGF-II mRNA and peptide overexpression in primary human colon cancers. Here we show that the IGF-II peptide content is increased in six primary colon cancers compared to the corresponding healthy tissues. The IGF-II transcripts in healthy and cancerous colon tissues were identified by Northern blotting and RT-PCR. Promoters P3 and P4 were active in most tissues. Relaxation of parental imprinting was observed in two tumors and one healthy tissue, without any correlation with the IGF-II transcript levels. Rearrangements of the IGF-II gene in two tumors containing very high amounts of IGF-II mRNA are described. Fragments containing the breakpoints were cloned by the vectorette-PCR strategy. In both tumors, the breakpoints occurred in repetitive sequences. In one tumor (T11), the breakpoint was localized 2 kb downstream the end of exon 9. The second tumor (T18) contains two modified alleles. In one rearranged allele the breakpoint is located in exon 9. The exact position of the breakpoint in the second rearranged allele has not been identified. In future experiments, the correlation between the gene rearrangements and IGF-II mRNA overexpression will be studied.
Research Center/Unit :
ULg - Université de Liège
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Winkler, Rose ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Anatomie et cytologie pathologiques
Delacroix, Laurence ; Université de Liège - ULiège > Département des sciences cliniques > GIGA-R:Immunopath. - Maladies infect. et médec. inter. gén.
Bensbaho, K.
Lambert, Stéphanie ; Centre Hospitalier Universitaire de Liège - CHU > Salle Cardiologie NDB
Collette, Julien ; Centre Hospitalier Universitaire de Liège - CHU > Chimie médicale
Hodzic, D.
Language :
English
Title :
IGF-II in primary human colorectal tumors: peptide level, activated promoters, parental imprinting and gene rearrangement.
1. Daughaday WH, Rotwein P. Insulin-like growth factor-I and -II. Peptide, mRNA and gene structure, serum and tissue concentration. Endocrine Rev 1989; 10: 68-91
2. Humbel RE. Insulin-like growth factors I and II. Europ J Biochem 1990; 190: 445-62
3. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocrine Rev 1995; 16: 3-35
4. Fowlkes JL. Insulin like growth factor-binding protein proteolysis. TEM 1997; 8: 299-305
5. Sussenbach JS, Rodenburg RJT, Scheper W, Holthuizen P. Transcriptional and post-transcriptional regulation of the human ICF-II gene expression. In: LeRoith D and Raizada MK (eds). Current directions in Insulin-like Growth Factor Research. Plenum Press, New York, 1994: 63-71
6. Giannoukakis N, Deal C, Paquette J, Goodyear CG, Polychronakos C. Parental genomic imprinting of the human IGF2 gene. Nature Genet 1993; 4: 98-101
7. De Moor CH, Jansen M, Sussenbach JS, Van Den Brande J. Differential polysomal localization of human insulin-like-growth-factor-2 mRNAs in cell lines and fetal liver. Eur J Biochem 1994; 222: 1017-24
8. Werner H, Le Roith D. The role of the insulin-like growth factor system in human cancer. Adv Cancer Res 1996; 68: 183-223
9. Singh P, Dai B, Yallampalli U, Xu Z. Expression of IGF-II and IGF binding proteins by colon cancer cells in relation to their growth response to IGFs. Am J Physiol 1994; 267: G608-G617
10. Singh P, Dai P, Yallampalli U, Lu X, Schroy PC. Proliferation and differentiation of a human colon cancer cell line (CaCo2) is associated with significant changes in the expression and secretion of insulin-like growth factor (IGF) IGF-II and IGF binding protein-4: role of IGF. Endocrinology 1996; 137: 1764-74
11. Schneid H, Holthuizen P, Sussenbach JS. Differential promoter activation in two human insulin-like growth factor-II-producing tumor cell lines. Endocrinology 1993; 132: 1145-50
12. Lambert S, Carlisi A, Collette J, Franchimont P, Gol-Winkler R. Insulin-like growth factor-II in two human colon-carcinoma cell lines: gene structure and expression and protein secretion. Int J Cancer 1992; 52: 404-8
13. Lahm H, Amstad P, Wyniger J, Yilmaz A, Fischer JR, Schreyer M, Givel JC. Blockade of the insulin-like growth-factor-I receptor inhibits growth of human colorectal cancer cells: evidence of a functional IGF-II-mediated autocrine loop. Int J Cancer 1994; 58: 452-9
14. Kinouchi Y, Hiwatashi N, Higashioka S, Nagashima F, Chida M, Toyota T. Relaxation of imprinting of the insulin-like growth factor II gene in colorectal cancer. Cancer Lett 1996; 107: 105-8
15. Tricoli JV, Rall LB, Karakousis CP, Herrera L, Petrelli NJ, Bell GI, Shows TB. Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinoma and liposarcoma. Cancer Res 1986; 46: 6169-73
16. Lambert S, Vivario J, BoniverJ, Gol-Winkler R. Abnormal expression and structural modification of the insulin-like growth-factor-II gene in human colorectal tumors. Int J Cancer 1990; 46: 404-8
17. Lambert S, Collette J, Gillis J, Franchimont P, Desaive C, Gol-Winkler R. Tumor IGF-II content in a patient with a colon adenocarcinoma correlates with abnormal expression of the gene. Int J Cancer 1991; 48: 826-30
18. Fourney RM, Miyakosui J, Day III RS, Paterson MC. Northern Blotting: efficient RNA staining and transfer. Focus (Gibco/BRL) 1988; 10: 5-7
19. Rainier S, Johnson LA, Dobry CJ, Ping AJ, Grundy PE, Feinberg AP. Relaxation of imprinted genes in human cancer. Nature 1993; 362: 747-9
20. Nielsen FC, Gammeltoft S, Christiansen J. Translational discrimination of RNAs coding for human Insulin-like growth factor II. J Biol Chem 1990; 265: 13431-4
21. Michell NP, Langman MJS, Eggo MC. Insulin-like growth factors and their binding proteins in human colonocytes: preferential degradation of insulin-like growth factor binding protein 2 in colon cancers. Br J Cancer 1997; 76: 60-6
22. Kawamoto K, Onodera H, Kondo S, Kan S, Ikeuchi D, Maetani S, Imamura M. Expression of insulin-like growth factor-2 can predict the prognosis of human colorectal cancer patients: correlation with tumor progression, proliferative activity and survival. Oncology 1998; 55: 242-8
24. Douc-Rasy S, Barrois M, Fogel S, Ahomadegbe JC, Stehelin D, Coll J, Riou G. High incidence of loss of heterozygosity and abnormal Imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Oncogene 1996; 12: 423-30
25. Gicquel C, Raffin-Sanson M-L, Gaston V, Bertagna X, Plouin P-F, Schlumberger M, Louvel A, Luton J-P, Le Bouc Y. Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors: study on a series of 82 tumors. J Clin Endocrinol Metab 1997; 82: 2559-65
